116 related articles for article (PubMed ID: 10427131)
1. Induction of apoptosis by N-(4-hydroxyphenyl)retinamide in glioma cells.
Saitoh Y; Goto T; Puduvalli VK; Murakami M; Kochi M; Levin VA; Kyritsis AP; Ushio Y
Int J Oncol; 1999 Sep; 15(3):499-504. PubMed ID: 10427131
[TBL] [Abstract][Full Text] [Related]
2. Growth inhibition and induction of apoptosis by fenretinide in small-cell lung cancer cell lines.
Kalemkerian GP; Slusher R; Ramalingam S; Gadgeel S; Mabry M
J Natl Cancer Inst; 1995 Nov; 87(22):1674-80. PubMed ID: 7473815
[TBL] [Abstract][Full Text] [Related]
3. Fenretinide activates caspases and induces apoptosis in gliomas.
Puduvalli VK; Saito Y; Xu R; Kouraklis GP; Levin VA; Kyritsis AP
Clin Cancer Res; 1999 Aug; 5(8):2230-5. PubMed ID: 10473110
[TBL] [Abstract][Full Text] [Related]
4. Is growth inhibition and induction of apoptosis in lung cancer cell lines by fenretinide [N-(4-hydroxyphenyl)retinamide] sufficient for cancer therapy?
Ohlmann CH; Jung C; Jaques G
Int J Cancer; 2002 Aug; 100(5):520-6. PubMed ID: 12124800
[TBL] [Abstract][Full Text] [Related]
5. Anticancer effects of fenretinide in human medulloblastoma.
Damodar Reddy C; Guttapalli A; Adamson PC; Vemuri MC; O'Rourke D; Sutton LN; Phillips PC
Cancer Lett; 2006 Jan; 231(2):262-9. PubMed ID: 16399227
[TBL] [Abstract][Full Text] [Related]
6. Neuroblastoma cell apoptosis induced by the synthetic retinoid N-(4-hydroxyphenyl)retinamide.
Di Vinci A; Geido E; Infusini E; Giaretti W
Int J Cancer; 1994 Nov; 59(3):422-6. PubMed ID: 7927952
[TBL] [Abstract][Full Text] [Related]
7. Fenretinide-induced apoptosis of human head and neck squamous carcinoma cell lines.
Scher RL; Saito W; Dodge RK; Richtsmeier WJ; Fine RL
Otolaryngol Head Neck Surg; 1998 Apr; 118(4):464-71. PubMed ID: 9560096
[TBL] [Abstract][Full Text] [Related]
8. 4-(N-hydroxyphenyl)retinamide can selectively induce apoptosis in human epidermoid carcinoma cells but not in normal dermal fibroblasts.
Ulukaya E; Kurt A; Wood EJ
Cancer Invest; 2001; 19(2):145-54. PubMed ID: 11296619
[TBL] [Abstract][Full Text] [Related]
9. Anti-proliferative activity of fenretinide in human hepatoma cells in vitro and in vivo.
Shentu J; Zhang B; Fan L; He Q; Yang B; Chen Z
Anticancer Drugs; 2007 Jan; 18(1):47-53. PubMed ID: 17159502
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of 4-HPR-induced apoptosis in glioma cells: evidences suggesting role of mitochondrial-mediated pathway and endoplasmic reticulum stress.
Tiwari M; Kumar A; Sinha RA; Shrivastava A; Balapure AK; Sharma R; Bajpai VK; Mitra K; Babu S; Godbole MM
Carcinogenesis; 2006 Oct; 27(10):2047-58. PubMed ID: 16675469
[TBL] [Abstract][Full Text] [Related]
11. N-(4-hydroxyphenyl) retinamide is cytotoxic to melanoma cells in vitro through induction of programmed cell death.
Montaldo PG; Pagnan G; Pastorino F; Chiesa V; Raffaghello L; Kirchmeier M; Allen TM; Ponzoni M
Int J Cancer; 1999 Apr; 81(2):262-7. PubMed ID: 10188729
[TBL] [Abstract][Full Text] [Related]
12. p38MAPK-Dependent sensitivity of Ewing's sarcoma family of tumors to fenretinide-induced cell death.
Myatt SS; Redfern CP; Burchill SA
Clin Cancer Res; 2005 Apr; 11(8):3136-48. PubMed ID: 15837770
[TBL] [Abstract][Full Text] [Related]
13. Fenretinide: a p53-independent way to kill cancer cells.
Corazzari M; Lovat PE; Oliverio S; Di Sano F; Donnorso RP; Redfern CP; Piacentini M
Biochem Biophys Res Commun; 2005 Jun; 331(3):810-5. PubMed ID: 15865936
[TBL] [Abstract][Full Text] [Related]
14. The impact of retinoic acid treatment on the sensitivity of neuroblastoma cells to fenretinide.
Armstrong JL; Martin S; Illingworth NA; Jamieson D; Neilson A; Lovat PE; Redfern CP; Veal GJ
Oncol Rep; 2012 Jan; 27(1):293-8. PubMed ID: 21964808
[TBL] [Abstract][Full Text] [Related]
15. Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)- retinamide in neuroblastoma cell lines.
Maurer BJ; Metelitsa LS; Seeger RC; Cabot MC; Reynolds CP
J Natl Cancer Inst; 1999 Jul; 91(13):1138-46. PubMed ID: 10393722
[TBL] [Abstract][Full Text] [Related]
16. Fenretinide activity in retinoid-resistant oral leukoplakia.
Lippman SM; Lee JJ; Martin JW; El-Naggar AK; Xu X; Shin DM; Thomas M; Mao L; Fritsche HA; Zhou X; Papadimitrakopoulou V; Khuri FR; Tran H; Clayman GL; Hittelman WN; Hong WK; Lotan R
Clin Cancer Res; 2006 May; 12(10):3109-14. PubMed ID: 16707609
[TBL] [Abstract][Full Text] [Related]
17. N-(4-hydroxyphenyl)retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid.
Delia D; Aiello A; Lombardi L; Pelicci PG; Grignani F; Grignani F; Formelli F; Menard S; Costa A; Veronesi U
Cancer Res; 1993 Dec; 53(24):6036-41. PubMed ID: 8261419
[TBL] [Abstract][Full Text] [Related]
18. Fenretinide and its relation to cancer.
Ulukaya E; Wood EJ
Cancer Treat Rev; 1999 Aug; 25(4):229-35. PubMed ID: 10448131
[TBL] [Abstract][Full Text] [Related]
19. 4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis in fenretinide-sensitive and fenretinide-resistant cell lines.
Villani MG; Appierto V; Cavadini E; Bettiga A; Prinetti A; Clagett-Dame M; Curley RW; Formelli F
Cancer Res; 2006 Mar; 66(6):3238-47. PubMed ID: 16540676
[TBL] [Abstract][Full Text] [Related]
20. Higher potency of N-(4-hydroxyphenyl)retinamide than all-trans-retinoic acid in induction of apoptosis in non-small cell lung cancer cell lines.
Zou CP; Kurie JM; Lotan D; Zou CC; Hong WK; Lotan R
Clin Cancer Res; 1998 May; 4(5):1345-55. PubMed ID: 9607596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
